HERAN Partners

HERAN Partners is a Belgian investment firm established in 2020 and located in Antwerp. Founded by Annie Vereecken, Katleen Vandersmissen, Joris Mortelmans, and Herman Verrelst, the firm specializes in the healthcare technology sector, particularly focusing on MedTech and digital health. HERAN Partners is dedicated to providing venture and growth capital to startups and scale-ups that possess strong technology platforms and significant market potential. The firm enhances its investment approach by leveraging a robust network, expertise, and mentorship, predominantly targeting opportunities within the European HealthTech landscape.

Katleen Vandersmissen

Managing Partner

Geoffrey D'hondt

Investment Director

7 past transactions

Nuclivision

Seed Round in 2025
Nuclivision specializes in the development of innovative radiotracers and treatments for oncology, focusing on enhancing nuclear medicine through advanced technology. The company offers a nuclear medicine software platform that supports physicians throughout the entire workflow, from image acquisition to diagnosis and follow-up. By enabling the assessment of cellular metabolism, Nuclivision's solutions improve efficiency and facilitate the integration of nuclear imaging processes. This technology allows physicians to scan more patients daily at reduced costs, ultimately enhancing the quality, safety, and accessibility of nuclear medicine for patients.

Broken String Biosciences

Series A in 2023
Broken String Biosciences is focused on developing a novel sequencing platform aimed at assessing genome stability to enhance the safety and efficacy of cell and gene therapies. By integrating advanced sequencing techniques with bioinformatics analysis and artificial intelligence, the company provides healthcare professionals with a comprehensive, data-driven approach to medicine. This innovative platform is designed to facilitate the development of the next generation of therapies, ensuring they are safer by design and capable of addressing various medical challenges. Through its efforts, Broken String Biosciences aims to unlock new possibilities in the realm of advanced therapeutic solutions.

Thirona

Series B in 2023
Thirona is a software solutions firm specializing in automated analysis tools for the healthcare industry, particularly in medical imaging. The company leverages artificial intelligence to develop software products that focus on analyzing thoracic CT scans, chest X-rays, and retinal images. Thirona also provides certified image analysis services that deliver precise and reproducible measurements from medical images. By enhancing the accuracy and efficiency of medical image analysis, Thirona enables hospitals to detect and address diseases more rapidly, thereby improving patient outcomes.

Hypervision Surgical

Seed Round in 2023
Hypervision Surgical is a company focused on enhancing surgical precision, safety, and efficiency through advanced imaging technology. It has developed a non-contact and non-invasive optical imaging system that utilizes hyperspectral imaging to analyze tissue in real-time. By splitting light into multiple spectral bands, the system enables clinicians to visualize and characterize tissues during surgery without the need for contrast agents, thereby reducing patient risk. This AI-powered solution facilitates advanced computer-assisted tissue analysis, equipping surgeons with critical data that supports informed decision-making during procedures. Hypervision Surgical aims to transform the landscape of surgery by guiding clinicians with innovative imaging solutions that prioritize patient safety and operational effectiveness.

LynxCare

Series A in 2022
LynxCare, established in 2015 and headquartered in San Francisco, specializes in an AI-powered data platform that collects, analyzes, and interprets both structured and unstructured data from diverse sources. This platform, designed for hospitals and clinics, empowers medical professionals with actionable insights, enabling them to enhance clinical efficiency and improve the quality of patient care.

Thirona

Venture Round in 2021
Thirona is a software solutions firm specializing in automated analysis tools for the healthcare industry, particularly in medical imaging. The company leverages artificial intelligence to develop software products that focus on analyzing thoracic CT scans, chest X-rays, and retinal images. Thirona also provides certified image analysis services that deliver precise and reproducible measurements from medical images. By enhancing the accuracy and efficiency of medical image analysis, Thirona enables hospitals to detect and address diseases more rapidly, thereby improving patient outcomes.

LynxCare

Venture Round in 2020
LynxCare, established in 2015 and headquartered in San Francisco, specializes in an AI-powered data platform that collects, analyzes, and interprets both structured and unstructured data from diverse sources. This platform, designed for hospitals and clinics, empowers medical professionals with actionable insights, enabling them to enhance clinical efficiency and improve the quality of patient care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.